(Q37541645)

20 August 2017

1 reference

title

Critical illness polyneuropathy and myopathy in the intensive care unit (English)

1 reference

critical illness polyneuropathy

20 August 2017

1 reference

1 reference

Wolfgang Zink

1

1 reference

20 August 2017

Rainer Kollmar

series ordinal

2

1 reference

20 August 2017

Stefan Schwab

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

20 August 2017

published in

Nature Reviews Neurology

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

7

1 reference

20 August 2017

page(s)

372-379

1 reference

Insulin therapy protects the central and peripheral nervous system of intensive care patients

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Cancer cachexia is regulated by selective targeting of skeletal muscle gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Apoptosis in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Polyneuropathy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Neuromuscular manifestations of critical illness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness myopathy and neuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness myopathy: sepsis-mediated failure of the peripheral nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Neuromuscular dysfunction acquired in critical illness: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Clinical review: Critical illness polyneuropathy and myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Paresis acquired in the intensive care unit: a prospective multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Acquired weakness, handgrip strength, and mortality in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness polyneuromyopathy: the electrophysiological components of a complex entity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Early development of critical illness myopathy and neuropathy in patients with severe sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Peripheral nerve function in sepsis and multiple organ failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Neurological complications of sepsis: critical illness polyneuropathy and myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Risk factors for the development of polyneuropathy and myopathy in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Does ICU-acquired paresis lengthen weaning from mechanical ventilation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

31 March 2020

ICU-acquired weakness

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Interventions for preventing critical illness polyneuropathy and critical illness myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Respiratory weakness is associated with limb weakness and delayed weaning in critical illness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness polyneuropathy. A complication of sepsis and multiple organ failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Myopathies in critical illness: characterization and nutritional aspects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Muscle force and fatigue in patients with sepsis and multiorgan failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Clinical and electrophysiological findings in critical illness polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Diagnosis and management of critical illness polyneuropathy and critical illness myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Acute neuromuscular weakness in the intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Approach to neuromuscular disorders in the intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness neuromuscular syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Electrophysiological tests in intensive care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Nerve excitability changes in critical illness polyneuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Nerve membrane excitability testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Direct stimulation: a useful technique

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Direct muscle stimulation in acute quadriplegic myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy--a reappraisal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Electrophysiologic techniques in critical illness-associated weakness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Origin of ICU acquired paresis determined by direct muscle stimulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Sepsis: stimulation of energy-dependent protein breakdown resulting in protein loss in skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

A porcine model of acute quadriplegic myopathy: a feasibility study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Myopathy in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness myopathy and neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness myopathy: deeper insights

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Risk factors for critical illness polyneuromyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

The role of future longitudinal studies in ICU survivors: understanding determinants and pathophysiology of weakness and neuromuscular dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Insulin therapy for the critically ill patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

One-year outcomes in survivors of the acute respiratory distress syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness myopathy: what is happening?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Mechanisms of neuromuscular dysfunction in critical illness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Understanding critical illness myopathy: approaching the pathomechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Apoptotic features accompany acute quadriplegic myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

The N-end rule pathway catalyzes a major fraction of the protein degradation in skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Sodium channel inactivation in an animal model of acute quadriplegic myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Muscle is electrically inexcitable in acute quadriplegic myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Muscle inexcitability in patients with reversible paralysis following steroids and neuromuscular blockade

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Possible role for nitric oxide dysregulation in critical illness myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Alterations in intracellular Ca2+-homeostasis of skeletal muscle fibers during sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units: Benefit Versus Harm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Dysregulation of sodium channel gating in critical illness myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Early intensive care unit mobility therapy in the treatment of acute respiratory failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Neuromuscular sequelae of critical illness.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2009.75

Clinical approach to the weak patient in the intensive care unit.

31 March 2020

1 reference

12 December 2020

Critical illness neuromyopathies

1 reference

12 December 2020

Distinction between acute myopathy syndrome and critical illness polyneuropathy

1 reference

12 December 2020

Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders

1 reference

12 December 2020

Critical illness myopathy and neuropathy

1 reference

12 December 2020

[Disseminated neuropathy following coma. On the differentation of so-called toxic polyneuropathy.]

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2009.75

1 reference

20 August 2017

1 reference